GSK3B and early-onset autosomal dominant Alzheimer disease: In an Alzheimer’s disease (AD) mouse model, GSK-3β (glycogen synthase kinase 3β) causes phosphorylation of DRP1 at Ser40 and Ser44, which promotes its GTPase activity, thereby increasing mitochondrial division and neuronal apoptosis [50].